Summary.-The radiosensitizing effect of iodoacetamide was studied in a C3H mouse mammary carcinoma together with its toxicity to the host. TCD50 or radiation dose to yield 50% tumour control frequency was determined in tumours treated or untreated with the agent. Results indicated that 15 mg/kg of iodoacetamide sensitized hypoxic tumour cells, as did atmospheric oxygen, and the sensitization was not detectable below this dose. Experiments with fractionated treatments suggested that the reoxygenation occurring during the treatment intervals of 24 hours might be more important in the sterilization of tumour cells than the agent.
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IT has been demonstrated that iodoacetamide (IA), one of the thiol-binding agents, enhanced the response to ionizing radiation of bacteria, particularly radioresistant bacteria (Dean and Alexander, 1962) and of mammalian cells (Bianchi et al., 1964) . Some short-lived transients of IA formed after irradiation were considered to be responsible for this effect (Dewey and Michael, 1965; Mullenger et al., 1967) . In this communication, the sensitizing effect of the agent to tumours was studied. The aim was to investigate how large a population of hypoxic tumour cells, which are the critical cells in radiotherapy, could be sensitized by the agent.
MATERIALS AND METHODS
Animal-tumour system.-C3H/He mice of both sexes were supplied by Funabashi Farm Co., Chiba. They were kept in small animal units in our Department and provided with purina pellets and water ad libitum. Third generation isotransplants derived from a single spontaneous C3H/He mouse mammary carcinoma were used in all the experiments. The spontaneous and first generation tumours were stored in liquid nitrogen and first generation tumours were transplanted into subcutaneous tissue of several female mice for experimental use as needed.
Preparation of single cell suspension.-Animals carrying second generation tumours were sacrificed by cervical dislocation and tumours were excised. Intact tumour tissue was minced finely with scissors and suspended in Hank's medium containing 5% foetal calf serum. The mince was sedimented in test tubes stood in crushed ice for 20 min. The supernatant was removed by syringe and passed through a swinny filter, and then centrifuged for 5 min. The sediment was resuspended with a small amount of Hank's medium and served for transplantation. Viable tumour cells were counted in a haemacytometer by use of the trypan-blue staining method.
Tumour irradiation.-An x-ray machine was operated at 180 kVp and 25 mA with a filter of 2 mm Al. Half value layer was 8-0 mm Al, target tumour distance was 19 cm. Dose rate at the tumour centre was 660 rad/min (Urano, Tanaka and Hayashi, 1972) . In order to obtain homogeneous dose distribution, animals were rotated halfway through the irradiation period. Local hypoxia was obtained by applying a heavy brass clamp above the tumour, while for air irradiation the tumours were irradiated when the animals were breathing normal air. For oxygenated irradiation of the tumour the animals were breathing 500 CO2 + 950O02 in a small plastic chamber. The animals were anaesthetized by intraperitoneal injection of Nembutal before irradiation.
Whole body irradiation.-Physical factors were: 180 kVp, 25 mA, 07 mm Cu of HVL and TSD 55 cm. Twelve animals, kept in a round plastic cage with 12 centripetal individual compartments, were irradiated simultaneously. The cage was set on a rotating table to distribute a constant dose. The dose rate in the centre of each mouse was 70 rad/min.
Experimental assay methods.-Three methods were employed, and a brief description of these is given below:
(a) The radiation dose to yield local control in 5000 of the irradiated tumours (TCD50) was found and used as the baseline in experiments to examine the sensitizing effect of the test materials on the tumours. Tumours were irradiated when they reached 8 mm in average diameter or 250 mm3. After irradiation, the animals were checked once a week for possible tumour recurrence for a period of 120 days (Urano et al., 1972) . (b) The determination of the number of viable tumour cells expected to give rise to a tumour in half of the recipients (TD50), was applied for experiments to test the cytotoxicity of the agent. The single cell suspension was admixed with the isologous tumour cells which had been irradiated lethally with 10,000 rad, in a ratio of 1: 103. This suspension was serially diluted two-to three-fold by Hank's medium into 6-8 doses.
Tumour take frequency was observed once a week for 80 days (Urano and Suit, 1971 Sensitization studies In the first series of experiments, irradiation was given in a single dose at 30 min after administration of IA.
As presented in Table III, TCD50 (15 mg/ kg IA, hypoxia)* was significantly less than TCD50 (without IA, hypoxia), while TCD50 (5 mg/kg IA, hypoxia) was equivalent to the control value. The ratio of TCD50 (without IA, hypoxia) to TCD50 (15 mg/kg IA, hypoxia) was 1P12, indicating that some fraction of hypoxic tumour cells were sensitized by the agent.
The second series of studies was performed with 3 fractionated doses. The first and second doses were conditioned at 1000 rad and the third dose was varied in dose level in each assay. The amount of IA was reduced to 10 mg/kg, since 3 injections each of 15 mg/kg would be too toxic to the host. As shown in the lower half of Table III , the TCD50 (non-treated, air) was significantly less than the TCD50 (non-treated, hypoxia), while the sensitizing effect of the agent was not observed in tumours irradiated under air nor under hypoxic condition.
Effect of IA on LD50/4
The LD50/4 after whole body irradiation of mice might reflect an x-ray response of intestinal crypt cells. The whole body irradiation was given 30 min after administration of 15 mg/kg IA. Animal death was observed mainly between 3 and 4 days after irradiation, with symptoms of severe diarrhoea. The LD50/4 for mice treated or untreated with IA was 870 or 980 rad respectively.
The ratio of LD50/4 of untreated to that of IA treated mice was 1-13, which was similar to the ratio of TCD50 (without IA, hypoxia) to TCD50 (15 mg/kg IA, hlypoxia).
DISCUSSION
Among the thiol-binding agents, IA is well documented as one of the most powerful radiosensitizers in the inactivation of bacteria (Dean and Alexander, 1965; Moroson and Tenney, 1968) of tumour cells were sensitized if irradiated under hypoxic conditions using the model described by Suit, Shalek and Wette (1965) . This calculation was also based on an assumption that the radiosensitivity of our tumour cells could be represented by an extrapolation number of 8 and D0 (dose to reduce survival from 1 to 1/e in the exponential portion of the survival curve) of 390 rad (unpublished data).
It has been estimated that this tumour contains 20-25% hypoxic cells (Suit and Maeda, 1967) . The present results indicate that approximately 85% of these original hypoxic cells were sensitized. Also, the fact that the TCD50 (15 mg/kg IA, hypoxia) was similar to the TCD50 (without IA, oxygen) suggests that 15 mg/kg IA had a similar sensitizing effect to oxygen. However, the IA was more toxic (40%o of LD50/30) to the animals than oxygen. Also, with fractionated doses, a sensitizing effect of IA is not observed in tumours irradiated under air, nor under hypoxic conditions. Therefore, IA is not considered to be of therapeutic advantage in this system.
